Ramachandran R, Nair C, Pillai A, Shekar S, Ajayachandran Nair R, Babu M
Indian J Otolaryngol Head Neck Surg. 2025; 77(2):680-685.
PMID: 40070770
PMC: 11890794.
DOI: 10.1007/s12070-024-05221-6.
Song K, Vijjhalwar R, Aye M, Comninos A, Schini M, Abbas A
J Endocr Soc. 2025; 9(2):bvae225.
PMID: 39876875
PMC: 11772554.
DOI: 10.1210/jendso/bvae225.
Xu L, Cao Y
Arch Dermatol Res. 2024; 317(1):100.
PMID: 39666073
DOI: 10.1007/s00403-024-03609-6.
Hyusein R, Atsev S, Boyukliev A, Petrov P, Velchev V, Penchev P
Cureus. 2024; 16(4):e57826.
PMID: 38721190
PMC: 11078121.
DOI: 10.7759/cureus.57826.
Yang L, Jing X, Pang H, Guan L, Li M
Endocr Connect. 2024; 13(5).
PMID: 38513354
PMC: 11046330.
DOI: 10.1530/EC-23-0492.
Intracranial germinoma combined with parathyroid adenoma in a male pediatric patient: A case report.
Zhang T, Yuan C, Lv J, Liu Y, Wu J
SAGE Open Med Case Rep. 2023; 11:2050313X231207561.
PMID: 37886631
PMC: 10599108.
DOI: 10.1177/2050313X231207561.
The Impact of Moderate Hypophosphatemia on the Clinical Management of Primary Hyperparathyroidism.
Gunes E, Gunes M
Cureus. 2023; 15(8):e44115.
PMID: 37638278
PMC: 10455043.
DOI: 10.7759/cureus.44115.
A Therapeutic Approach to Primary Hyperparathyroidism: A Collaborative Evaluation Between Endocrinology and Surgery.
Behnke A, Tershak D, Abel W, Bankole A
Cureus. 2023; 15(1):e34157.
PMID: 36843806
PMC: 9949684.
DOI: 10.7759/cureus.34157.
Cognitive deficits in primary hyperparathyroidism - what we know and what we do not know: A narrative review.
Chandran M, Yeh L, Jong M, Bilezikian J, Parameswaran R
Rev Endocr Metab Disord. 2022; 23(5):1079-1087.
PMID: 35994179
DOI: 10.1007/s11154-022-09750-9.
Advances in the diagnosis and the management of primary hyperparathyroidism.
Islam A
Ther Adv Chronic Dis. 2021; 12:20406223211015965.
PMID: 34178298
PMC: 8202248.
DOI: 10.1177/20406223211015965.
Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.
Hasenmajer V, Puliani G, Minnetti M, Sbardella E, Mastroianni C, DEttorre G
Adv Exp Med Biol. 2021; 1369:17-32.
PMID: 33782903
DOI: 10.1007/5584_2021_629.
Surgical Treatment of Primary Hyperparathyroidism: Which Therapy to Whom?.
Aygun N, Uludag M
Sisli Etfal Hastan Tıp Bul. 2020; 53(3):201-214.
PMID: 32377085
PMC: 7192265.
DOI: 10.14744/SEMB.2019.56873.
Recent advances in the understanding and management of primary hyperparathyroidism.
Goldfarb M, Singer F
F1000Res. 2020; 9.
PMID: 32148764
PMC: 7043104.
DOI: 10.12688/f1000research.21569.1.
Reconstruction of Brown's Tumor of the Mandible with Fibula Osteocutaneous Flap.
Katrolia D, Mandal D, Anand K, Jharia K, Kumari N, Roy C
Indian J Plast Surg. 2019; 52(2):254-255.
PMID: 31602147
PMC: 6785329.
DOI: 10.1055/s-0039-1696789.
Osteitis fibrosa cystica masquerading as bone neoplasm.
Garla V, Akhtar I, Salim S, Subauste A
BMJ Case Rep. 2018; 2018.
PMID: 29735505
PMC: 5950634.
DOI: 10.1136/bcr-2018-224546.
Occult urolithiasis in asymptomatic primary hyperparathyroidism.
Tay Y, Liu M, Bandeira L, Bucovsky M, Lee J, Silverberg S
Endocr Res. 2018; 43(2):106-115.
PMID: 29400579
PMC: 6042842.
DOI: 10.1080/07435800.2018.1431275.
Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X, Shen L, Gu X
Urolithiasis. 2018; 46(5):453-457.
PMID: 29350243
DOI: 10.1007/s00240-018-1038-x.
Primary hyperparathyroidism.
Walker M, Silverberg S
Nat Rev Endocrinol. 2017; 14(2):115-125.
PMID: 28885621
PMC: 6037987.
DOI: 10.1038/nrendo.2017.104.
Clinical and laboratory profile of primary hyperparathyroidism in Kashmir Valley: A single-center experience.
Misgar R, Dar P, Masoodi S, Ahmad M, Wani K, Wani A
Indian J Endocrinol Metab. 2016; 20(5):696-701.
PMID: 27730083
PMC: 5040053.
DOI: 10.4103/2230-8210.190560.
Primary hyperparathyroidism.
Bilezikian J, Cusano N, Khan A, Liu J, Marcocci C, Bandeira F
Nat Rev Dis Primers. 2016; 2:16033.
PMID: 27194212
PMC: 5385896.
DOI: 10.1038/nrdp.2016.33.
